Type 2 Diabetes in South Asians: A pathophysiologic focus on the Asian-Indian epidemic

Current Diabetes Reports

Volumn 4, Issue 3, 2004, Pages 213-218

  Bajaj, Mandeep ^a   Banerji, Mary Ann ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ASIAN; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETOGENESIS; DISEASE PREDISPOSITION; DYSLIPIDEMIA; EPIDEMIC; HUMAN; INDIAN; INSULIN RESISTANCE; LOW BIRTH WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN CALORIE MALNUTRITION; RACE DIFFERENCE; REVIEW; SOUTH ASIA;

EID: 3142628459     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-004-0026-4     Document Type: Review

References (64)

1. McKeigue P, Miller GJ, Marmot MG: Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 1989, 42:597-609.
2. McKeigue PM, Shah B, Marmott MG: Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991, 337:382-386.
3. Cruikshank JK, Cooper J, Burnett M, et al.: Ethnic differences in fasting C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991, 338:842-847.
4. Omar MA, Asmal AC: Insulin response to oral glucose in young African and Indian non-insulin dependent diabetes patients in Natal. Trop Geogr Med 1983, 35:59-64.
5. Dowse GK, Zimmet PZ, Alberti KG, et al.: Serum insulin distribution and reproducibility of the relationship between 2 hour insulin and plasma glucose in Asian Indian, Creole and Chinese Maurutians. Metabolism 1993, 42:1232-1241.
6. Mohan V, Sharp PS, Cloke HR et al.: Serum immunoreactive insulin responses to glucose load in Asian Indian and European type 2 diabetic patients and control subjects. Diabetologia 1986, 29:235-237.
7. Snehalatha C, Ramachandran A, Vijay V, et al.: Differences in plasma insulin responses in urban and rural Indians: a study in Southern India. Diabet Med 1994, 11:445-448.
8. Schofield DJ, Behall KM, Bethana SJ, et al.: A study on Asian and American vegetarians: indications of a racial predisposition to glucose intolerance. J Clin Nutr 1987, 46:955-961.
9. Simmons D, Williams DR, Powell MJ: Prevalence of diabetes in different regional and religious South Asian Indian communities in Coventry. Diabet Med 1992, 9:428-431.
10. Verma NPS, Mehta AP, Madhu S, et al.: The prevalence of known diabetes in urban Indian community: the Darya Ganj Diabetes Survey. BMJ 1986, 293:423-424.
11. Ramachandran A, Snehalatha C, Dharmaraj D, et al.: Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care 1992, 15:1348-1355.
12. Omar MA, Seedat MA, Dyer RB, et al.: South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 1994, 17:70-73.
13. Beckles GL, Miller GJ, Kirkwood BR, et al.: High total and cardiovascular disease mortality in adults of Asian Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1986, 1:1298-1300.
14. Ramachandran A, Snehalatha C, Kapur A, et al.: High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001, 44:1094-1101.
15. Zimmet P: Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 2000, 247:301-310.
16. Abate N, Chandalia M: Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications 2001, 15:320-327.
17. Motala AA, Omar MA, Gouws E: High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance. Diabetes 1993, 42:556-563.
18. Lillioja S, Mott DM, Howard BV, et al.: Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1998, 318:1217-1225.
19. Saad MF, Knowler WC, Pettitt DJ, et al.: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988, 319:1500-1505.
20. Haffner SM, Miettinen H, Gaskill SP, et al.: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995, 44:1386-1391.
21. Dowse GK, Zimmet PZ, Collins VR: Insulin levels and the natural history of glucose intolerance in Nauruans. Diabetes 1996, 45:1367-1372.
22. Jallut D, Golay A, Munger R, et al.: Impaired glucose tolerance and diabetes in obesity: a 6 year follow-up study of glucose metabolism. Metabolism 1990, 39:1068-1075.
23. Bajaj M, DeFronzo RA: Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 2003, 10:311-323.
24. Banerji MA, Norin AJ, Chaiken RL, et al.: HLA-DQ associations distinguish insulin-resistant and insulin-sensitive variants of NIDDM in black Americans. Diabetes Care 1993, 16:429-433.
25. Banerji MA, Faridi N, Atluri R, et al.: Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999, 84:137-144.
26. Raji A, Seely EW, Arky RA, et al.: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001, 86:5366-5371.
27. Reaven GM, Hollenbeck C, Jeng CY, et al.: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 hours in patients with NIDDM. Diabetes 1988, 37:1020-1024.
28. Groop LC, Bonadonna RC, Del Prato, et al.: Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989, 84:205-215.
29. Bajaj M, Berria R, Pratipanawatr T, et al.: Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans. Am J Physiol Endocrinol Metab 2002, 283:E346-E352.
30. Kashyap S, Belfort R, Gastaldelli A, et al.: A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003, 52:2461-2474.
31. Groop L, Saloranta C, Shank M, et al.: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1991, 72:96-107.
32. Reaven GM: The fourth Musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia 1995, 38:3-13.
33. Gulli G, Ferrannini E, Stern M, et al.: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992, 41:1575-1586.
34. Haffner SM, Miettinen H, Stern MP: Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. J Clin Endocrinol Metab 1996, 81:1846-1851.
35. Viswanathan M, Mohan M, Snehalatha C, et al.: High prevalence of type 2 diabetes among the offspring of conjugal type 2 diabetic parents. Diabetologia 1985, 28:907-910.
36. Bonadonna RC, Zych K, Boni C, et al.: Time dependence of the interaction between lipid and glucose metabolism in humans. Am J Physiol 1989, 20:E49-E56.
37. Chandalia M, Abate N, Garg A, et al.: Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999, 84:2329-2335.
38. Wahrenberg H, Lonnqvist F, Arner P: Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 1989, 84:458-467.
39. Banerji MA, Lebowitz J, Chaiken RL, et al.: Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol 1997, 273:E425-432.
40. Bjorntorp P: 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990, 10:493-496.
41. Greco AV, Mingrone G, Giancaterini A, et al.: Insulin resistance in morbid obesity. Reversal with intramyocellular fat depletion. Diabetes 2002, 51:144-151.
42. Ryysy L, Hakkinen AM, Goto T, et al.: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000, 49:749-758.
43. Bajaj M, Suraamornkul S, Pratipanawatr T, et al.: Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 2003, 52:1364-1370.
44. McKeigue PM, Pierpont T, Ferrie JE, et al.: Relationship of glucose intolerance to body fat pattern in South Asians and Europeans. Diabetologia 1992, 35:785-791.
45. Hu FB, Manson JE, Stampfer MJ, et al.: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Eng1 J Med 2001, 345:790-797.
46. Neel JV: Diabetes mellitus: a thrifty genotype rendered detrimental by 'progress'. Am J Hum Genet 1962, 14:353-362.
47. Lindsay RS, Bennett PH: Type 2 diabetes, the thrifty phenotype - an overview. Br Med Bull 2001, 60:21-32.
48. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994, 265:2037-2048.
49. Abate N: Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 2000, 14:154-174.
50. Lepretre F, Vionnet N, Budhan S, et al.: Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery. Diabetes Metab 1998, 24:244-250.
51. Hales CN, Barker DJ, Clark PM, et al.: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022.
52. Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35:595-601.
53. Phillips DI: Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 1996, 39:1119-1122.
54. Bajaj JS, Bajaj M: Malnutrition-related diabetes mellitus: perception and perspective. In Diabetes 1994. Edited by Baba S, Kaneko T. Philadelphia, PA: Elsevier Science; 1994:267-272.
55. Yajnik CS, Lubree HG, Rege SS, et al.: Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 2002, 87:5575-5580.
56. Wild S, McKeigue P: Cross-sectional analysis of mortality by country of birth in England and Wales, 1970-1992. BMJ 1997, 314:705-710.
57. Ginsberg HN: Insulin resistance and cardiovascular disease. J Clin Invest 2000, 106:453-458.
58. Misra A, Reddy RB, Reddy KS, et al.: Clustering of impaired glucose tolerance, hyperinsulinemia and dyslipidemia in young north Indian patients with coronary heart disease: a preliminary case-control study. Indian Heart J 1999, 51:275-280.
59. Bajaj M, Purohit A: Insulin resistance, dyslipidemia and coronary artery disease in type 2 diabetes mellitus - the Indian perspective. In Coronary Artery Disease in Indians: A Global Perspective. Edited by Sethi KK. New Delhi: Cardiology Society of India; 1999:92-97.
60. Despres JP, Lamarche B, Mauriege P, et al.: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957.
61. Fontbonne AM, Eschwege EM: Insulin and cardiovascular disease. Paris prospective study. Diabetes Care 1991, 14:461-469.
62. Hoogeveen RC, Gambhir JK, Gambhir DS, et al.: Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001, 42:631-638.
63. Anand SS, Enas EA, Pogue J, et al.: Elevated lipoprotein(a) levels in South Asians in North America. Metabolism 1998, 47:182-184.
64. Mohan V, Deepa R, Haranath S, et al.: Lipoprotein (a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 1998, 21:1819-1823.